Root Financial Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
KCM
BBA
Root Financial Partners's CLDX Position: Q3 2026 in Review
Root Financial Partners opened a new position in Celldex Therapeutics (CLDX) in Q3 2026: 64 shares worth $2.07K. The stake represents ﹤0.01% of the portfolio and ranks #2625 among its holdings.
249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.
- Root Financial Partners held 64 shares of Celldex Therapeutics worth $2.07K as of Q3 2026.
- Celldex Therapeutics was a new Root Financial Partners position in Q3 2026.
- Celldex Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2625 holding.
- 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.